1578154-74-1Relevant articles and documents
A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles
Lin, Xianfeng,Shi, Houguang,Zhang, Weixing,Qiu, Zongxing,Zhou, Zheng,Dey, Fabian,Zhong, Sheng,Qiu, Hongxia,Xie, Jianxun,Zhou, Xue,Yang, Guang,Tang, Guozhi,Shen, Hong C.,Zhu, Wei
, p. 10352 - 10361 (2019/11/29)
Described herein is a new approach to mitigate CYP3A4 induction. In this unconventional approach, a fine-tuning of the dihedral angle between the C4 phenyl and the dihydropyrimidine core of the heteroaryldihydropyrimidine (HAP) class of capsid inhibitors
PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDINE ANALOGUES
-
Page/Page column 13; 14; 15; 16; 19; 20, (2016/07/27)
The present invention relates to a process for synthesizing a compound of formula (I), (I), wherein R1 is phenyl, which is unsubstituted, or once, twice or three times substituted by halogen; R2 is C1-6/su
Novel 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
-
Paragraph 0215; 0320; 0424, (2015/02/19)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4 and A are as described herein, compositions including the compounds and methods of using the compounds.
6-AMINO ACID HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
Page/Page column 95; 121; 122, (2014/03/26)
The invention provides novel compounds having the general formula:, wherein R1, R2, R3, R4 and A are as described herein, compositions including the compounds and methods of using the compounds.